Kathrin Ute Jansen

机构：Pfizer (United States) · ORCID：0000-0001-5354-4202

发表论文 297 篇 · 总被引 50136 次 · h-index 83

代表论文

• Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants (2023 · New England Journal of Medicine · 被引 1005)
• Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults (2023 · New England Journal of Medicine · 被引 683)
• Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years (2021 · Clinical Infectious Diseases · 被引 178)
• Potential for Maternally Administered Vaccine for Infant Group B Streptococcus (2023 · New England Journal of Medicine · 被引 149)
• Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study (2022 · New England Journal of Medicine · 被引 146)
• Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years (2023 · New England Journal of Medicine · 被引 123)